FR3275888: Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof

Acces sibility Controls

The invention relates to the development of the cationic progesterone compounds as a novel anti-tumor agent. The invention provides a method for the preparation of novel series of progesterone derivatives. The invention also provides information related to highly selective anti-cancer activities of these compounds in wide range of cancer cell irrespective of their progesterone receptor status. Thus, the disclosed cationic progesterone compounds offer a viable option as anti-cancer therapeutics.

Patent No:: FR3275888
Application No:: 17179456
Filing Date:: 04-07-2017
Issue Date:: 25-09-2019
Applicant:: CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad
Inventor(s):: Sujan Kumar Mondal; Sudhakar Jinka; Rajkumar Banerjee
Country:: France

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Acces sibility Controls

Patents